OMB control number

Registration of Human Drug Compounding Outsourcing Facilities under section 503B of the FFDCA and Associated fees under section 744K

OMB 0910-0776 ยท HHS/FDA.

OMB 0910-0776

This information collection helps to support implementation of section 503B of the Federal Food, Drug, and Cosmetic Act (FD&C Act) and the Drug Quality and Security Act (DQSA) regarding the registration of human drug compounding outsourcing facilities. The information collection also implements provisions applicable to registered outsourcing facilities and the assessment and remission of user fees under section 744K of the FD&C Act.

The latest form for Registration of Human Drug Compounding Outsourcing Facilities under section 503B of the FFDCA and Associated fees under section 744K expires 2027-01-31 and is listed under ICR 202311-0910-015.

All Historical Document Collections

Historical document collections
ReferenceFilingReceivedConcludedAction
202311-0910-015 Extension without change of a currently approved collection 2023-12-01 Approved without change
202011-0910-001 Revision of a currently approved collection 2020-11-27 Approved without change
201710-0910-008 Extension without change of a currently approved collection 2017-10-19 Approved without change
201409-0910-002 New collection (Request for a new OMB Control Number) 2014-09-08 Approved without change

OMB Details

Registration of Oursourcing Facilitites and Payment of Fees

Federal Enterprise Architecture: Health - Health Care Services

Information collection instruments
FormNameElectronic accessType
Form 3908Outsourcing Facilities for Human Drug Compounding Small Business Establishment Fee Reduction RequestFillable Fileable SignableForm and instruction

Review document collections for all forms, instructions, and supporting documents - including paper/printable forms.